查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1642444

2025-2033 年按定序類型、產品類型、技術、應用、最終用戶和地區分類的下一代定序市場報告

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 126 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球次世代定序（ IMARC Group ）市場規模達233億美元。由於技術的不斷進步、臨床應用的增加、對生物資訊工具和資料分析解決方案的需求不斷增加、對精準醫療的日益關注以及研發力度的加強，NGS 市場正在迅速擴大。

新一代定序 (NGS) 是一種平行定序技術，可確定脫氧核糖核酸 (DNA) 部分中的核苷酸序列。它涉及多種程序，例如合成定序（SBS）和離子半導體、單分子即時定序（SMRT）和奈米孔定序。它是一種經濟高效的解決方案，可幫助醫療專業人員以高精度和高速度獲得精確的結果。它還促進臨床診斷、個人化和遺傳醫學以及農業和動物研究領域的研究。目前，它被用於藥物基因組學以升級藥物遞送過程。

下一代定序 (NGS) 市場趨勢：

全球老年人口不斷成長，癌症、心血管和神經系統疾病等各種慢性疾病的盛行率不斷上升，是積極影響市場的關鍵因素之一。這也可以歸因於擴大使用遺傳圖譜來指導科學家分析導致醫療狀況的基因。此外，液體活體組織切片在癌症診斷中的廣泛採用，以及擴大利用NGS技術引入非侵入性癌症生物標記進行即時癌症監測和檢測，正在創造積極的市場前景。與此一致的是，定序儀的持續技術創新，例如整合雲端運算系統以增強資料安全性和管理，正在加強市場成長。除此之外，各國政府為改善醫療基礎設施而持續提供的資金也為市場成長提供了動力。此外，領導企業對分子生物學、技術工程和定序化學研發 (R&D) 活動的投資不斷增加，帶來了良好的市場前景。

下一代定序市場細分：

按定序類型分類：

全基因組定序

標靶重測序

全外顯子定序

RNA定序

晶片測序

從頭測序

甲基定序

其他

由於 NGS 市場上有許多公司提供標靶重測序服務，標靶重測序代表了最大的細分市場。

按產品類型分類：

儀器儀表

試劑及耗材

軟體和服務

試劑和耗材代表最常用的產品類型，有助於樣品製備、DNA 分離、樣品淨化、目標富集和品質保證。

按技術分類：

合成定序

離子半導體定序

單分子即時定序

奈米孔定序

其他

合成定序因其在 DNA 定序中的高精度以及在 NGS 儀器中的日益普及而得到了廣泛的應用。此外，它還提供最高的無錯誤吞吐量結果。

按應用分類：

生物標記與癌症

藥物發現與個人化醫療

基因篩檢

診斷

農業和動物研究

其他

由於癌症盛行率不斷上升以及人們對早期診斷和治療益處的認知不斷提高，生物標記和癌症目前在市場上佔據主導地位。

按最終用戶分類：

學術機構與研究中心

醫院和診所

製藥與生物技術公司

其他

由於NGS解決方案在研究計畫中的應用越來越多，學術機構和研究中心佔據了大部分市場佔有率。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

由於該地區擁有技術先進的醫療保健研究框架，加上存在多個採用 NGS 提供基因檢測服務的臨床實驗室，北美在市場上表現出明顯的主導地位。

競爭格局：

該報告還分析了市場的競爭格局，一些主要參與者包括安捷倫科技、Becton Dickinson and Company、10x Genomics、BGI Group、Eurofins Scientific、F. Hoffmann-La Roche AG、Illumina Inc.、Genewiz、Macrogen 、Oxford Nanopore Technologies、Pacific Biosciences、PerkinElmer、Thermo Fisher Scientific、Qiagen NV、GenapSys Inc. 等。

本報告回答的關鍵問題

  • 下一代定序（NGS）市場有多大
  • 2025-2033年全球次世代定序（NGS）市場的預期成長率是多少
  • 推動全球次世代定序（NGS）市場的關鍵因素是什麼
  • COVID-19 對全球次世代定序 (NGS) 市場有何影響
  • 根據定序類型，全球次世代定序（NGS）市場的詳細情形如何
  • 根據產品類型，全球次世代定序（NGS）市場的詳細情形如何
  • 基於科技的全球次世代定序（NGS）市場的分化是什麼
  • 基於應用的全球次世代定序（NGS）市場的詳細情形如何
  • 9. 全球次世代定序（NGS）市場基於最終用戶的詳細情形如何
  • 10. 全球次世代定序（NGS）市場的關鍵區域有哪些？
  • 11. 全球次世代定序（NGS）市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 下一代定序（NGS）市場有多大？ 2025-2033年全球次世代定序（NGS）市場的預期成長率是多少？
  • 推動全球次世代定序（NGS）市場的關鍵因素是什麼？
  • COVID-19 對全球次世代定序 (NGS) 市場有何影響？
  • 根據定序類型，全球次世代定序（NGS）市場的詳細情形如何？
  • 根據產品類型，全球次世代定序 (NGS) 市場的詳細情形如何？
  • 基於技術的全球次世代定序（NGS）市場的詳細情形如何？
  • 基於應用的全球次世代定序（NGS）市場的詳細情形如何
  • 基於最終用戶的全球次世代定序 (NGS) 市場的詳細情形如何？
  • 全球次世代定序（NGS）市場的關鍵區域有哪些？
  • 全球次世代定序（NGS）市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球下一代定序市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依排序類型

  • 全基因組定序
    • 市場趨勢
    • 市場預測
  • 標靶重測序
    • 市場趨勢
    • 市場預測
  • 全外顯子定序
    • 市場趨勢
    • 市場預測
  • RNA定序
    • 市場趨勢
    • 市場預測
  • 晶片測序
    • 市場趨勢
    • 市場預測
  • 從頭測序
    • 市場趨勢
    • 市場預測
  • 甲基定序
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依產品類型

  • 儀器儀表
    • 市場趨勢
    • 市場預測
  • 試劑及耗材
    • 市場趨勢
    • 市場預測
  • 軟體和服務
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依技術

  • 定序：合成法
    • 市場趨勢
    • 市場預測
  • 離子半導體定序
    • 市場趨勢
    • 市場預測
  • 單分子即時定序
    • 市場趨勢
    • 市場預測
  • 奈米孔定序
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按應用

  • 生物標記與癌症
    • 市場趨勢
    • 市場預測
  • 藥物發現與個人化醫療
    • 市場趨勢
    • 市場預測
  • 基因篩檢
    • 市場趨勢
    • 市場預測
  • 診斷
    • 市場趨勢
    • 市場預測
  • 農業和動物研究
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 學術機構與研究中心
    • 市場趨勢
    • 市場預測
  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 製藥與生物技術公司
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格指標

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • 10x Genomics
    • BGI Group
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Genewiz
    • Macrogen Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen NV
    • Genapsys Inc.
Product Code: SR112024A2039

The global next-generation sequencing (NGS) market size reached USD 23.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 85.4 Billion by 2033, exhibiting a growth rate (CAGR) of 15.5% during 2025-2033. The market for NGS is expanding rapidly due to ongoing technological advancements, increasing use in clinical applications, escalating demand for bioinformatics tools and data analysis solutions, a rising focus on precision medicine, as well as enhanced research and development efforts.

Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.

Next-Generation Sequencing (NGS) Market Trends:

The growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R&D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.

Next Generation Sequencing Market Segmentation:

Breakup by Sequencing Type:

Whole Genome Sequencing

Targeted Resequencing

Whole Exome Sequencing

RNA Sequencing

CHIP Sequencing

De Novo Sequencing

Methyl Sequencing

Others

Targeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.

Breakup by Product Type:

Instruments

Reagents and Consumables

Software and Services

Reagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.

Breakup by Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Single-Molecule Real-Time Sequencing

Nanopore Sequencing

Others

Sequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.

Breakup by Application:

Biomarker and Cancer

Drug Discovery and Personalized Medicine

Genetic Screening

Diagnostics

Agriculture and Animal Research

Others

Biomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.

Breakup by End-User:

Academic Institutes & Research Centers

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Others

Academic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report

  • 1. How big is the next generation sequencing (NGS) market?
  • 2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2025-2033?
  • 3. What are the key factors driving the global next-generation sequencing (NGS) market?
  • 4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
  • 5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
  • 6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
  • 7. What is the breakup of the global next-generation sequencing (NGS) market based on technology?
  • 8. What is the breakup of the global next-generation sequencing (NGS) market based on the application
  • 9. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?
  • 10. What are the key regions in the global next-generation sequencing (NGS) market?
  • 11. Who are the key players/companies in the global next-generation sequencing (NGS) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Targeted Resequencing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 RNA Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CHIP Sequencing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 De Novo Sequencing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Methyl Sequencing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nanopore Sequencing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomarker and Cancer
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Discovery and Personalized Medicine
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Genetic Screening
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Diagnostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Agriculture and Animal Research
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Academic Institutes & Research Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals & Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 10x Genomics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 BGI Group
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Eurofins Scientific
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Genewiz
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Macrogen Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Oxford Nanopore Technologies
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pacific Biosciences
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Perkinelmer Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Qiagen N.V.
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials
      • 16.3.14.4 SWOT Analysis
    • 16.3.15 Genapsys Inc.
      • 16.3.15.1 Company Overview
      • 16.3.15.2 Product Portfolio

List of Figures

  • Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
  • Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2024
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2024
  • Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
  • Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
  • Figure 112: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million USD), 2025-2033
  • Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Next-Generation Sequencing Market Structure
  • Table 9: Global: Next-Generation Sequencing Market: Key Players